These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6862293)

  • 1. Phase II trial of galactitol 1,2:5,6-dianhydro (NSC 132313) in the treatment of advanced gynecologic malignancies: a Gynecologic Oncology Group study.
    Stehman FB; Blom J; Blessing JA; Ehrlich CE; Mangan C
    Gynecol Oncol; 1983 Jun; 15(3):381-90. PubMed ID: 6862293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II evaluation of dianhydrogalactitol in the treatment of advanced non-squamous cervical carcinoma. A Gynecologic Oncology Group study.
    Stehman FB; Blessing JA; Homesley HD; Currie JL; Yordan EL
    Invest New Drugs; 1984; 2(3):331-3. PubMed ID: 6511240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dianhydrogalactitol and cisplatin in combination for advanced cancer of the uterine cervix.
    Vogl SE; Seltzer V; Camacho F; Calanog A
    Cancer Treat Rep; 1982 Oct; 66(10):1809-12. PubMed ID: 6889913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II evaluation of dianhydrogalactitol in lung cancer: a Southwest Oncology Group Study.
    Haas CD; Baker L; Thigpen T
    Cancer Treat Rep; 1981; 65(1-2):115-7. PubMed ID: 6261943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II evaluation of dianhydrogalactitol in advanced head and neck carcinomas.
    Edmonson JH; Frytak S; Letendre L; Kvols LK; Eagan RT
    Cancer Treat Rep; 1979; 63(11-12):2081-3. PubMed ID: 526941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II evaluation of dianhydrogalactitol in the treatment of advanced endometrial adenocarcinoma: a Gynecologic Oncology Group Study.
    Stehman FB; Blessing JA; Delgado G; Louka M
    Cancer Treat Rep; 1983; 67(7-8):737-8. PubMed ID: 6871892
    [No Abstract]   [Full Text] [Related]  

  • 7. cis-Dichlorodiammineplatinum(II) in the treatment of gynecologic malignancies: phase II trials by the Gynecologic Oncology Group.
    Thigpen T; Shingleton H; Homesley H; LaGasse L; Blessing J
    Cancer Treat Rep; 1979; 63(9-10):1549-55. PubMed ID: 498154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II evaluation of galactitol in head and neck cancer: a Southwest Oncology Group Study.
    Haas CD; Lehane D; Bottomley R
    Med Pediatr Oncol; 1983; 11(4):281-3. PubMed ID: 6888328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of dianhydrogalactitol in metastatic malignant melanoma: a Southwest Oncology Group study.
    Thigpen JT; Al-Sarraf M; Hewlett JS
    Cancer Treat Rep; 1979 Apr; 63(4):525-8. PubMed ID: 445506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dianhydrogalactitol (NSC-132313): phase II study in solid tumors.
    de Jager R; Brugarolas A; Hansen H; Cavalli F; Ryssel H; Siegenthaler P; Clarysse A; Renard J; Kenis Y; Alberto P
    Eur J Cancer (1965); 1979 Jul; 15(7):971-4. PubMed ID: 385328
    [No Abstract]   [Full Text] [Related]  

  • 11. Echinomycin (NSC 526417) in recurrent and metastatic nonsquamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
    Muss HB; Blessing JA; Hanjani P; Malfetano JH; Kemp GM; Webster K
    Am J Clin Oncol; 1992 Aug; 15(4):363-4. PubMed ID: 1325110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies.
    Sutton GP; Blessing JA; Photopulos G; Berman ML; Homesley HD
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):68-72. PubMed ID: 2539647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of dianhydrogalactitol in advanced renal cell carcinoma: a Southwest Oncology Group study.
    Ratanatharathorn V; Baker LH; Balducci L; Talley RW; Hoogstraten B
    Cancer Treat Rep; 1982 May; 66(5):1231-2. PubMed ID: 7083224
    [No Abstract]   [Full Text] [Related]  

  • 14. A phase II evaluation of mitolactol in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Stehman FB; Blessing JA; McGehee R; Barrett RJ
    J Clin Oncol; 1989 Dec; 7(12):1892-5. PubMed ID: 2685182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Echinomycin (NSC 526417) in recurrent and metastatic squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group (GOG).
    Muss HB; Blessing JA; Eddy GL; McGehee R
    Invest New Drugs; 1992 Apr; 10(1):25-6. PubMed ID: 1607251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gynecologic Oncology Group experience with ifosfamide.
    Sutton GP; Blessing JA; Photopulos G; Berman ML; Homesley HD
    Semin Oncol; 1990 Apr; 17(2 Suppl 4):6-10. PubMed ID: 2159188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminothiadiazole (NSC #4728) in patients with advanced cervical carcinoma. A phase II study of the Gynecologic Oncology Group.
    Asbury RF; Blessing JA; Mortel R; Homesley HD; Malfetano J
    Am J Clin Oncol; 1987 Aug; 10(4):299-301. PubMed ID: 3618541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of 1,2:5,6-dianhydrogalactitol in studies on cell kinetics-directed chemotherapy schedules in human tumors in vivo.
    Barranco SC; Townsend CM; Costanzi JJ; May JT; Baltz R; O'Quinn AG; Leipzig B; Hokanson KM; Guseman LF; Boerwinkle WR
    Cancer Res; 1982 Jul; 42(7):2899-2905. PubMed ID: 7083178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of VP-16-213 in the treatment of advanced squamous cell carcinoma of the cervix and adenocarcinoma of the ovary: a Gynecologic Oncology Group Study.
    Slayton RE; Creasman WT; Petty W; Bundy B; Blessing JA
    Cancer Treat Rep; 1979; 63(11-12):2089-92. PubMed ID: 526942
    [No Abstract]   [Full Text] [Related]  

  • 20. Echinomycin (NSC 526417) in squamous-cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
    Muss HB; Blessing JA; Malfetano J
    Am J Clin Oncol; 1990 Jun; 13(3):191-3. PubMed ID: 2346124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.